Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-106a-5p BMP2 1.39 6.0E-5 -2.2 0 miRNATAP -0.25 0 NA
2 hsa-miR-106b-5p BMP2 1.47 0 -2.2 0 miRNATAP -0.32 7.0E-5 NA
3 hsa-miR-142-5p BMP2 1.3 0 -2.2 0 PITA; miRNATAP -0.19 0.00333 NA
4 hsa-miR-17-5p BMP2 2.07 0 -2.2 0 TargetScan -0.28 5.0E-5 NA
5 hsa-miR-20a-5p BMP2 2.65 0 -2.2 0 miRNATAP -0.24 0.00012 NA
6 hsa-miR-335-3p BMP2 1.51 0 -2.2 0 mirMAP -0.26 0.00065 NA
7 hsa-miR-421 BMP2 0.17 0.53528 -2.2 0 PITA; miRanda -0.26 9.0E-5 NA
8 hsa-miR-590-3p BMP2 0.84 0.00129 -2.2 0 PITA; miRanda; mirMAP -0.31 5.0E-5 NA
9 hsa-miR-106b-5p BMP7 1.47 0 -1 0.05546 mirMAP -0.45 0.00015 NA
10 hsa-miR-130b-5p BMP7 1.54 0 -1 0.05546 mirMAP -0.43 0 NA
11 hsa-miR-17-5p BMP7 2.07 0 -1 0.05546 mirMAP -0.32 0.0013 NA
12 hsa-miR-532-3p CTNNB1 -0.68 0.01476 -0.01 0.94149 miRNAWalker2 validate -0.11 1.0E-5 NA
13 hsa-miR-134-5p EPB41L5 0.17 0.62286 -1.18 0 MirTarget -0.13 0 NA
14 hsa-miR-148a-3p EPB41L5 2.31 0 -1.18 0 MirTarget -0.18 0 NA
15 hsa-miR-148a-5p EPB41L5 1.46 0 -1.18 0 mirMAP -0.14 4.0E-5 NA
16 hsa-miR-152-3p EPB41L5 0.66 0.0013 -1.18 0 MirTarget -0.26 0 NA
17 hsa-miR-424-5p EPB41L5 1.26 1.0E-5 -1.18 0 MirTarget -0.12 7.0E-5 NA
18 hsa-miR-590-5p EPB41L5 2.07 0 -1.18 0 miRanda -0.15 9.0E-5 NA
19 hsa-miR-139-5p FAM83D -2.27 0 2.05 0 miRanda -0.4 0 NA
20 hsa-miR-3065-5p FAM83D 0.65 0.09995 2.05 0 mirMAP -0.29 0 NA
21 hsa-miR-486-5p FAM83D -4.39 0 2.05 0 miRanda -0.21 0 NA
22 hsa-miR-146b-5p FGFR2 1.09 1.0E-5 -2.39 0 miRanda -0.18 0.00873 NA
23 hsa-miR-19b-1-5p FGFR2 1.71 0 -2.39 0 miRNAWalker2 validate; miRTarBase -0.27 0.00061 NA
24 hsa-miR-542-3p FGFR2 1.62 0 -2.39 0 miRanda -0.19 0.00349 NA
25 hsa-miR-590-3p FGFR2 0.84 0.00129 -2.39 0 miRanda -0.38 0 NA
26 hsa-miR-130b-3p FOXF2 1.83 0 -1.7 0 miRNATAP -0.54 0 NA
27 hsa-miR-142-3p FOXF2 3.98 0 -1.7 0 miRanda -0.14 0.00021 NA
28 hsa-miR-182-5p FOXF2 3.22 0 -1.7 0 miRNAWalker2 validate; miRNATAP -0.37 0 25738520 miR 182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer; In the present study we aimed to investigate the role of miR-182 in colorectal cancer CRC and identify the regulation of FoxF2 by miR-182; The direct binding of miR-182 to the 3' untranslated region 3'UTR of FoxF2 mRNA was confirmed using a luciferase reporter gene assay
29 hsa-miR-19a-3p FOXF2 2.12 0 -1.7 0 miRNATAP -0.35 0 NA
30 hsa-miR-19b-3p FOXF2 2.11 0 -1.7 0 miRNATAP -0.35 0 NA
31 hsa-miR-200c-3p FOXF2 0.38 0.08422 -1.7 0 miRNATAP -0.27 1.0E-5 NA
32 hsa-miR-301a-3p FOXF2 2.7 0 -1.7 0 miRNATAP -0.32 0 NA
33 hsa-miR-429 FOXF2 2.38 0 -1.7 0 PITA; miRanda; miRNATAP -0.13 0.00296 NA
34 hsa-miR-454-3p FOXF2 1.49 0 -1.7 0 miRNATAP -0.42 0 NA
35 hsa-miR-590-3p FOXF2 0.84 0.00129 -1.7 0 PITA; miRanda -0.33 0 NA
36 hsa-miR-9-5p FOXF2 4.99 0 -1.7 0 miRNATAP -0.17 0 NA
37 hsa-miR-96-5p FOXF2 3.04 0 -1.7 0 TargetScan; miRNATAP -0.42 0 NA
38 hsa-miR-146b-5p GSK3B 1.09 1.0E-5 -0.32 0.0051 miRanda -0.12 0 NA
39 hsa-miR-181a-5p GSK3B -0.38 0.05621 -0.32 0.0051 mirMAP -0.13 0 NA
40 hsa-miR-181b-5p GSK3B 0.67 0.00024 -0.32 0.0051 mirMAP -0.14 0 NA
41 hsa-miR-199a-5p GSK3B 1.31 0 -0.32 0.0051 PITA; miRanda; miRNATAP -0.12 0 NA
42 hsa-miR-199b-5p GSK3B 2.14 0 -0.32 0.0051 PITA; miRanda; miRNATAP -0.1 0 NA
43 hsa-miR-26b-5p GSK3B 0.72 5.0E-5 -0.32 0.0051 miRNATAP -0.16 0 NA
44 hsa-miR-29a-3p GSK3B 0.1 0.5732 -0.32 0.0051 miRNATAP -0.12 7.0E-5 NA
45 hsa-miR-29b-3p GSK3B 3.11 0 -0.32 0.0051 miRTarBase; miRNATAP -0.12 0 NA
46 hsa-miR-342-3p GSK3B -0.13 0.56103 -0.32 0.0051 miRanda -0.12 0 NA
47 hsa-miR-664a-3p GSK3B 0.44 0.02142 -0.32 0.0051 mirMAP -0.14 0 NA
48 hsa-let-7a-3p HGF 0.17 0.43183 -1.47 2.0E-5 mirMAP -0.22 0.00866 NA
49 hsa-miR-141-3p HGF 3.37 0 -1.47 2.0E-5 MirTarget; TargetScan -0.4 0 NA
50 hsa-miR-200a-3p HGF 3.15 0 -1.47 2.0E-5 MirTarget -0.25 0 NA
51 hsa-miR-203a-3p HGF 1.07 0.0039 -1.47 2.0E-5 MirTarget -0.15 0.0003 NA
52 hsa-miR-26b-5p HGF 0.72 5.0E-5 -1.47 2.0E-5 MirTarget; miRNATAP -0.31 0.00059 NA
53 hsa-miR-29a-5p HGF 1.9 0 -1.47 2.0E-5 mirMAP -0.29 1.0E-5 NA
54 hsa-miR-30b-5p HGF 0.36 0.13803 -1.47 2.0E-5 mirMAP -0.23 0.00049 NA
55 hsa-miR-421 HGF 0.17 0.53528 -1.47 2.0E-5 miRanda -0.19 0.00222 NA
56 hsa-miR-429 HGF 2.38 0 -1.47 2.0E-5 miRanda -0.33 0 NA
57 hsa-miR-542-3p HGF 1.62 0 -1.47 2.0E-5 miRanda -0.19 0.00164 NA
58 hsa-miR-590-3p HGF 0.84 0.00129 -1.47 2.0E-5 miRanda; mirMAP -0.35 0 NA
59 hsa-miR-590-5p HGF 2.07 0 -1.47 2.0E-5 miRanda -0.41 0 NA
60 hsa-miR-651-5p HGF 1.67 0 -1.47 2.0E-5 MirTarget -0.28 0 NA
61 hsa-miR-7-1-3p HGF 2.61 0 -1.47 2.0E-5 mirMAP -0.29 5.0E-5 NA
62 hsa-miR-139-5p HIF1A -2.27 0 0.42 0.01526 miRanda -0.12 1.0E-5 NA
63 hsa-miR-195-3p HIF1A -1.33 0 0.42 0.01526 MirTarget -0.14 6.0E-5 NA
64 hsa-miR-320a HIF1A -0.96 0 0.42 0.01526 miRanda -0.13 0.00665 NA
65 hsa-miR-660-5p HIF1A 2.05 0 0.42 0.01526 MirTarget -0.16 0 NA
66 hsa-let-7d-5p HMGA2 -0.62 6.0E-5 3.12 0.00011 miRNAWalker2 validate; miRTarBase; MirTarget -0.65 0.00736 NA
67 hsa-miR-195-3p HMGA2 -1.33 0 3.12 0.00011 mirMAP -0.43 0.0073 NA
68 hsa-miR-195-5p HMGA2 -1.02 5.0E-5 3.12 0.00011 MirTarget -0.45 0.00378 NA
69 hsa-miR-204-5p HMGA2 -1.02 0.00767 3.12 0.00011 miRNATAP -0.28 0.005 27095441; 26406941 We identified high mobility group protein A2 HMGA2 as a novel direct target of miR-204 and showed that miR-204 expression was decreased while HMGA2 expression was increased in CRC cell lines; Additionally both MiR-204 overexpression and HMGA2 inhibition attenuated cell proliferation whereas forced expression of HMGA2 partly restored the inhibitory effect of miR-204 on HCT116 and SW480 cells; Taken together our present study elucidated that miR-204 upregulated 5-Fu chemosensitivity via the downregulation of HMGA2 in colorectal cancer and provided significant insight into the mechanism of 5-Fu resistance in colorectal cancer patients;MiR 204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer; Analysis using publicly available algorithms has found that high mobility group AT-hook 2 HMGA2 a key transcriptional regulatory factor is a potential target of microRNA-204 miR-204; Some studies have shown that both miR-204 and HMGA2 are associated with cancer development; We examined the possible relationship between miR-204 and HMGA2 in the development of thyroid cancer; MiR-204 was downregulated in the thyroid cancer specimens and cell lines and targeted the 3^\prime untranslated region of HMGA2 directly
70 hsa-miR-29b-2-5p HMGA2 0.35 0.19484 3.12 0.00011 mirMAP -0.69 0 NA
71 hsa-miR-30b-5p HMGA2 0.36 0.13803 3.12 0.00011 mirMAP -0.66 2.0E-5 NA
72 hsa-miR-30d-3p HMGA2 0 0.98646 3.12 0.00011 MirTarget -0.83 0 NA
73 hsa-miR-30d-5p HMGA2 -0.92 4.0E-5 3.12 0.00011 mirMAP -1.03 0 NA
74 hsa-miR-32-5p HMGA2 0.88 6.0E-5 3.12 0.00011 miRNATAP -0.51 0.00603 NA
75 hsa-miR-326 HMGA2 -0.99 0.00335 3.12 0.00011 miRNATAP -0.42 0.00013 NA
76 hsa-miR-486-5p HMGA2 -4.39 0 3.12 0.00011 miRanda -0.24 0.00642 NA
77 hsa-miR-664a-3p HMGA2 0.44 0.02142 3.12 0.00011 mirMAP -0.93 0 NA
78 hsa-miR-664a-5p HMGA2 -0.09 0.66227 3.12 0.00011 MirTarget -0.73 5.0E-5 NA
79 hsa-miR-139-5p HNRNPAB -2.27 0 0.65 0 miRanda -0.12 0 NA
80 hsa-miR-107 LEF1 0.66 0 0.59 0.00774 miRanda -0.26 0.00074 NA
81 hsa-miR-3065-3p LEF1 0.38 0.30796 0.59 0.00774 miRNATAP -0.12 1.0E-5 NA
82 hsa-miR-3065-5p LEF1 0.65 0.09995 0.59 0.00774 miRNATAP -0.13 0 NA
83 hsa-let-7a-3p LIMS1 0.17 0.43183 -0.7 0.00015 mirMAP -0.15 0.00066 NA
84 hsa-miR-148b-5p LIMS1 1.39 0 -0.7 0.00015 MirTarget -0.21 0 NA
85 hsa-miR-182-5p LIMS1 3.22 0 -0.7 0.00015 MirTarget; miRNATAP -0.12 0.00027 NA
86 hsa-miR-186-5p LIMS1 0.85 0 -0.7 0.00015 mirMAP -0.23 0.00018 NA
87 hsa-miR-29a-3p LIMS1 0.1 0.5732 -0.7 0.00015 MirTarget; miRNATAP -0.18 0.00022 NA
88 hsa-miR-29b-3p LIMS1 3.11 0 -0.7 0.00015 MirTarget; miRNATAP -0.25 0 NA
89 hsa-miR-30b-5p LIMS1 0.36 0.13803 -0.7 0.00015 MirTarget -0.32 0 NA
90 hsa-miR-30c-5p LIMS1 -0.33 0.1236 -0.7 0.00015 MirTarget -0.28 0 NA
91 hsa-miR-30d-3p LIMS1 0 0.98646 -0.7 0.00015 mirMAP -0.16 8.0E-5 NA
92 hsa-miR-30d-5p LIMS1 -0.92 4.0E-5 -0.7 0.00015 MirTarget -0.14 0.00037 NA
93 hsa-miR-30e-5p LIMS1 1.6 0 -0.7 0.00015 MirTarget -0.17 0.00019 NA
94 hsa-miR-429 LIMS1 2.38 0 -0.7 0.00015 miRanda; miRNATAP -0.22 0 NA
95 hsa-miR-7-1-3p LIMS1 2.61 0 -0.7 0.00015 mirMAP -0.11 0.00311 NA
96 hsa-miR-96-5p LIMS1 3.04 0 -0.7 0.00015 TargetScan; miRNATAP -0.23 0 NA
97 hsa-miR-338-3p LOXL2 0.73 0.05063 1.02 0.00103 miRanda -0.18 0 NA
98 hsa-let-7a-5p LOXL3 -1.37 0 -0.11 0.58907 miRNATAP -0.19 0.00024 NA
99 hsa-let-7d-5p LOXL3 -0.62 6.0E-5 -0.11 0.58907 miRNATAP -0.19 0.00168 NA
100 hsa-let-7f-5p LOXL3 -0.05 0.83408 -0.11 0.58907 miRNATAP -0.17 1.0E-5 NA
101 hsa-let-7g-5p LOXL3 0.08 0.58308 -0.11 0.58907 miRNATAP -0.19 0.00289 NA
102 hsa-miR-2110 LOXL3 -1.92 0 -0.11 0.58907 miRNATAP -0.14 4.0E-5 NA
103 hsa-miR-200c-3p NOG 0.38 0.08422 -0.7 0.1118 MirTarget; miRNATAP -0.24 0.00944 NA
104 hsa-miR-28-5p NOTCH1 1.2 0 -1.08 0 miRanda -0.24 7.0E-5 NA
105 hsa-miR-664a-3p RBPJ 0.44 0.02142 0.07 0.55019 mirMAP -0.13 2.0E-5 NA
106 hsa-miR-30a-5p SNAI1 -0.92 0.00076 -0.76 0.00279 miRTarBase; miRNATAP -0.14 0.00089 24954667; 27212164; 21633953 We identified SNAI1 as a direct target of miR-30a and demonstrated miR-30a as a novel regulator of EMT by targeting SNAI1 indicating its potential therapeutic value for reducing invasion and metastasis of HCC;Knockdown of endogenous miR-30a promoted the elongated fibroblast-like morphologic alteration of SGC-7901 cells and also enhanced Snail and Vimentin expression; MiR-30a overexpression induced morphological changes from an extended fibroblast-like morphology to more epithelial-like morphology in SGC-7901/DDP cells and decreased Snail and Vimentin level;MicroRNA 30a inhibits epithelial to mesenchymal transition by targeting Snai1 and is downregulated in non small cell lung cancer; Forced re-introduction of miR-30a significantly altered cell morphology in vitro invasion and migration of invasive cell lines this being paralleled by a downregulation of Snai1 and upregulation of E-cadherin expression; These results suggest that miR-30a targets Snai1 inhibits invasion and metastasis and is downregulated in NSCLC
107 hsa-miR-30b-5p SNAI1 0.36 0.13803 -0.76 0.00279 miRTarBase; miRNATAP -0.29 0 NA
108 hsa-miR-30c-5p SNAI1 -0.33 0.1236 -0.76 0.00279 miRTarBase; miRNATAP -0.24 1.0E-5 NA
109 hsa-miR-30d-5p SNAI1 -0.92 4.0E-5 -0.76 0.00279 miRTarBase; miRNATAP -0.4 0 26501435 miR 30d Blocked Transforming Growth Factor β1 Induced Epithelial Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells; Luciferase activity assay was performed to verify the direct inhibition of Snail by miR-30d; Furthermore Snail was identified as the direct target of miR-30d; Our results revealed that miR-30d functioned as a suppressor of ovarian cancer progression by decreasing Snail expression and thus blocking TGF-β1-induced EMT process suggesting the potentiality of miR-30d analogs to be used as therapeutics for ovarian cancer
110 hsa-miR-30e-5p SNAI1 1.6 0 -0.76 0.00279 miRTarBase -0.3 0 NA
111 hsa-miR-335-5p SNAI1 -0.47 0.0677 -0.76 0.00279 miRNAWalker2 validate -0.16 0.0019 NA
112 hsa-miR-107 SNAI2 0.66 0 -0.55 0.05725 miRanda -0.45 1.0E-5 NA
113 hsa-miR-148b-3p SNAI2 0.48 0.00265 -0.55 0.05725 miRNAWalker2 validate -0.56 0 NA
114 hsa-miR-182-5p SNAI2 3.22 0 -0.55 0.05725 miRNAWalker2 validate; miRNATAP -0.28 0 NA
115 hsa-miR-200b-3p SNAI2 1.55 0 -0.55 0.05725 TargetScan -0.44 0 NA
116 hsa-miR-200c-3p SNAI2 0.38 0.08422 -0.55 0.05725 miRNATAP -0.45 0 NA
117 hsa-miR-335-3p SNAI2 1.51 0 -0.55 0.05725 mirMAP -0.28 1.0E-5 NA
118 hsa-miR-375 SNAI2 0.62 0.1492 -0.55 0.05725 miRanda -0.28 0 NA
119 hsa-miR-429 SNAI2 2.38 0 -0.55 0.05725 PITA; miRanda; miRNATAP -0.34 0 NA
120 hsa-miR-532-5p SNAI2 0.58 0.00232 -0.55 0.05725 PITA -0.39 0 NA
121 hsa-miR-96-5p SNAI2 3.04 0 -0.55 0.05725 miRNATAP -0.27 0 NA
122 hsa-miR-335-3p SOX9 1.51 0 0.5 0.27822 mirMAP -0.27 0.00601 NA
123 hsa-miR-107 TGFB2 0.66 0 -1.55 1.0E-5 miRanda -0.36 0.00389 NA
124 hsa-miR-141-3p TGFB2 3.37 0 -1.55 1.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan; miRNATAP -0.4 0 NA
125 hsa-miR-142-3p TGFB2 3.98 0 -1.55 1.0E-5 miRNATAP -0.19 5.0E-5 NA
126 hsa-miR-148a-3p TGFB2 2.31 0 -1.55 1.0E-5 MirTarget; miRNATAP -0.32 0 NA
127 hsa-miR-148b-3p TGFB2 0.48 0.00265 -1.55 1.0E-5 MirTarget -0.6 0 NA
128 hsa-miR-186-5p TGFB2 0.85 0 -1.55 1.0E-5 mirMAP -0.41 0.0004 NA
129 hsa-miR-193b-3p TGFB2 1.1 0.00082 -1.55 1.0E-5 MirTarget; miRNATAP -0.17 0.00038 NA
130 hsa-miR-200a-3p TGFB2 3.15 0 -1.55 1.0E-5 MirTarget; miRNATAP -0.15 0.0012 25813153 Tumor suppressive microRNA 200a inhibits renal cell carcinoma development by directly targeting TGFB2; By performing quantitative real-time PCR ELISA and luciferase reporter assays transforming growth factor beta2 TGFB2 was validated as a direct target gene of miR-200a; Moreover siRNA-mediated knockdown of TGFB2 partially phenocopied the effect of miR-200a overexpression; These results suggest that miR-200a suppresses RCC development via directly targeting TGFB2 indicating that miR-200a may present a novel target for diagnostic and therapeutic strategies in RCC
131 hsa-miR-203a-3p TGFB2 1.07 0.0039 -1.55 1.0E-5 MirTarget -0.13 0.0032 NA
132 hsa-miR-21-5p TGFB2 4.38 0 -1.55 1.0E-5 miRNAWalker2 validate -0.23 0.00013 NA
133 hsa-miR-29b-3p TGFB2 3.11 0 -1.55 1.0E-5 miRTarBase; MirTarget; miRNATAP -0.32 0 NA
134 hsa-miR-301a-3p TGFB2 2.7 0 -1.55 1.0E-5 MirTarget; miRNATAP -0.16 0.00349 NA
135 hsa-miR-324-5p TGFB2 1.07 5.0E-5 -1.55 1.0E-5 miRanda -0.28 0 NA
136 hsa-miR-330-5p TGFB2 0.17 0.33643 -1.55 1.0E-5 miRanda -0.3 0.0014 NA
137 hsa-miR-335-3p TGFB2 1.51 0 -1.55 1.0E-5 mirMAP -0.36 0 NA
138 hsa-miR-375 TGFB2 0.62 0.1492 -1.55 1.0E-5 miRNAWalker2 validate -0.2 0 NA
139 hsa-miR-454-3p TGFB2 1.49 0 -1.55 1.0E-5 MirTarget; miRNATAP -0.28 0.00017 NA
140 hsa-miR-589-3p TGFB2 1.34 2.0E-5 -1.55 1.0E-5 MirTarget -0.14 0.00952 NA
141 hsa-miR-590-3p TGFB2 0.84 0.00129 -1.55 1.0E-5 mirMAP -0.25 0.00081 NA
142 hsa-miR-590-5p TGFB2 2.07 0 -1.55 1.0E-5 miRanda; miRNATAP -0.33 0 NA
143 hsa-miR-181a-5p TGFBR1 -0.38 0.05621 -0.17 0.2761 mirMAP; miRNATAP -0.11 0.00188 NA
144 hsa-miR-181b-5p TGFBR1 0.67 0.00024 -0.17 0.2761 mirMAP; miRNATAP -0.11 0.00619 NA
145 hsa-miR-186-5p TGFBR1 0.85 0 -0.17 0.2761 mirMAP -0.19 0.00024 NA
146 hsa-miR-301a-3p TGFBR1 2.7 0 -0.17 0.2761 miRNATAP -0.13 0 NA
147 hsa-miR-339-5p TGFBR1 0.54 0.04881 -0.17 0.2761 miRanda -0.11 2.0E-5 NA
148 hsa-miR-454-3p TGFBR1 1.49 0 -0.17 0.2761 mirMAP; miRNATAP -0.19 0 NA
149 hsa-miR-500a-5p TGFBR1 0.65 0.01047 -0.17 0.2761 mirMAP -0.11 6.0E-5 NA
150 hsa-miR-590-5p TGFBR1 2.07 0 -0.17 0.2761 PITA; miRanda -0.1 0.00115 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 EPITHELIAL TO MESENCHYMAL TRANSITION 28 56 8.853e-76 4.119e-72
2 MESENCHYMAL CELL DIFFERENTIATION 28 134 6.6e-63 1.536e-59
3 MESENCHYME DEVELOPMENT 28 190 2.989e-58 3.476e-55
4 STEM CELL DIFFERENTIATION 28 190 2.989e-58 3.476e-55
5 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 28 513 1.37e-45 1.275e-42
6 CELLULAR COMPONENT MORPHOGENESIS 28 900 1.3e-38 1.008e-35
7 CELL DEVELOPMENT 28 1426 6.01e-33 3.995e-30
8 TISSUE DEVELOPMENT 28 1518 3.517e-32 2.046e-29
9 TISSUE MORPHOGENESIS 20 533 5.859e-26 3.029e-23
10 MESENCHYME MORPHOGENESIS 11 38 4.945e-24 2.301e-21
11 MORPHOGENESIS OF AN EPITHELIUM 17 400 1.642e-22 6.946e-20
12 EMBRYONIC ORGAN DEVELOPMENT 17 406 2.119e-22 8.217e-20
13 RESPONSE TO GROWTH FACTOR 17 475 3.096e-21 1.108e-18
14 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 20 957 7.059e-21 2.346e-18
15 GLAND DEVELOPMENT 16 395 9.712e-21 3.013e-18
16 REGULATION OF STEM CELL DIFFERENTIATION 12 113 1.637e-20 4.76e-18
17 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 20 1021 2.543e-20 6.961e-18
18 ORGAN MORPHOGENESIS 19 841 2.817e-20 7.282e-18
19 REGULATION OF OSSIFICATION 13 178 4.7e-20 1.151e-17
20 EMBRYO DEVELOPMENT 19 894 8.895e-20 2.069e-17
21 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 20 1142 2.321e-19 5.144e-17
22 HEART MORPHOGENESIS 13 212 4.792e-19 1.013e-16
23 REGULATION OF CARTILAGE DEVELOPMENT 10 63 5.704e-19 1.154e-16
24 POSITIVE REGULATION OF GENE EXPRESSION 22 1733 8.535e-19 1.655e-16
25 NEGATIVE REGULATION OF GENE EXPRESSION 21 1493 1.345e-18 2.406e-16
26 REGULATION OF CELL DIFFERENTIATION 21 1492 1.326e-18 2.406e-16
27 EMBRYONIC MORPHOGENESIS 16 539 1.403e-18 2.418e-16
28 REGULATION OF ORGAN MORPHOGENESIS 13 242 2.749e-18 4.568e-16
29 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 8 24 3.554e-18 5.703e-16
30 EPITHELIUM DEVELOPMENT 18 945 9.879e-18 1.532e-15
31 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 9 50 1.186e-17 1.781e-15
32 REGULATION OF EPITHELIAL CELL PROLIFERATION 13 285 2.351e-17 3.418e-15
33 POSITIVE REGULATION OF CELL DIFFERENTIATION 17 823 3.322e-17 4.684e-15
34 REGULATION OF CELL DEVELOPMENT 17 836 4.317e-17 5.909e-15
35 REGULATION OF CELL PROLIFERATION 20 1496 4.633e-17 6.16e-15
36 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 20 1517 6.082e-17 7.86e-15
37 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 21 1805 6.621e-17 8.326e-15
38 TUBE DEVELOPMENT 15 552 9.161e-17 1.122e-14
39 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 15 554 9.666e-17 1.153e-14
40 TUBE MORPHOGENESIS 13 323 1.204e-16 1.4e-14
41 MESODERM MORPHOGENESIS 9 66 1.729e-16 1.962e-14
42 LOCOMOTION 18 1114 1.8e-16 1.994e-14
43 FORMATION OF PRIMARY GERM LAYER 10 110 2.014e-16 2.179e-14
44 SKELETAL SYSTEM DEVELOPMENT 14 455 2.448e-16 2.589e-14
45 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 18 1152 3.244e-16 3.355e-14
46 HEART DEVELOPMENT 14 466 3.412e-16 3.451e-14
47 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 20 1672 4.04e-16 3.916e-14
48 REGULATION OF CELLULAR COMPONENT MOVEMENT 16 771 4.032e-16 3.916e-14
49 CARDIOVASCULAR SYSTEM DEVELOPMENT 16 788 5.679e-16 5.284e-14
50 CIRCULATORY SYSTEM DEVELOPMENT 16 788 5.679e-16 5.284e-14
51 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 17 983 6.415e-16 5.853e-14
52 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 16 801 7.34e-16 6.543e-14
53 SENSORY ORGAN DEVELOPMENT 14 493 7.453e-16 6.543e-14
54 ENDOCARDIAL CUSHION MORPHOGENESIS 7 22 7.85e-16 6.764e-14
55 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 17 1008 9.733e-16 8.234e-14
56 CONNECTIVE TISSUE DEVELOPMENT 11 194 1e-15 8.309e-14
57 CELL MOTILITY 16 835 1.408e-15 1.13e-13
58 LOCALIZATION OF CELL 16 835 1.408e-15 1.13e-13
59 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 18 1275 1.918e-15 1.513e-13
60 REPRODUCTIVE SYSTEM DEVELOPMENT 13 408 2.487e-15 1.929e-13
61 REGULATION OF STEM CELL PROLIFERATION 9 88 2.619e-15 1.997e-13
62 NEGATIVE REGULATION OF CELL DEATH 16 872 2.774e-15 2.082e-13
63 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 7 26 3.017e-15 2.228e-13
64 PATTERN SPECIFICATION PROCESS 13 418 3.399e-15 2.471e-13
65 POSITIVE REGULATION OF LOCOMOTION 13 420 3.615e-15 2.588e-13
66 CARTILAGE DEVELOPMENT 10 147 3.955e-15 2.747e-13
67 IN UTERO EMBRYONIC DEVELOPMENT 12 311 3.94e-15 2.747e-13
68 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 8 53 4.174e-15 2.856e-13
69 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 18 1360 5.918e-15 3.99e-13
70 GASTRULATION 10 155 6.785e-15 4.51e-13
71 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 11 236 8.8e-15 5.767e-13
72 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 18 1395 9.211e-15 5.953e-13
73 ENDOCARDIAL CUSHION DEVELOPMENT 7 32 1.535e-14 9.773e-13
74 NEGATIVE REGULATION OF CELL COMMUNICATION 17 1192 1.554e-14 9.773e-13
75 POSITIVE REGULATION OF CELL DEVELOPMENT 13 472 1.622e-14 1.007e-12
76 REGULATION OF CELL DEATH 18 1472 2.344e-14 1.435e-12
77 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 7 34 2.449e-14 1.48e-12
78 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 16 1004 2.493e-14 1.487e-12
79 POSITIVE REGULATION OF CELL PROLIFERATION 15 814 2.803e-14 1.651e-12
80 NEGATIVE REGULATION OF CELL PROLIFERATION 14 643 2.902e-14 1.688e-12
81 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 8 67 3.034e-14 1.743e-12
82 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 19 1784 3.28e-14 1.861e-12
83 MESODERM DEVELOPMENT 9 118 3.993e-14 2.239e-12
84 CELL PROLIFERATION 14 672 5.311e-14 2.942e-12
85 EMBRYONIC ORGAN MORPHOGENESIS 11 279 5.565e-14 3.046e-12
86 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 19 1848 6.239e-14 3.376e-12
87 REGULATION OF BINDING 11 283 6.506e-14 3.48e-12
88 UROGENITAL SYSTEM DEVELOPMENT 11 299 1.189e-13 6.287e-12
89 REGULATION OF WNT SIGNALING PATHWAY 11 310 1.766e-13 9.232e-12
90 REGIONALIZATION 11 311 1.829e-13 9.456e-12
91 PALATE DEVELOPMENT 8 85 2.203e-13 1.126e-11
92 DIGESTIVE SYSTEM DEVELOPMENT 9 148 3.189e-13 1.597e-11
93 CELL FATE COMMITMENT 10 227 3.193e-13 1.597e-11
94 DIGESTIVE TRACT MORPHOGENESIS 7 48 3.309e-13 1.638e-11
95 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 13 602 3.624e-13 1.775e-11
96 RESPONSE TO ENDOGENOUS STIMULUS 17 1450 3.846e-13 1.864e-11
97 NEGATIVE REGULATION OF CELL DIFFERENTIATION 13 609 4.197e-13 2.013e-11
98 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 11 337 4.395e-13 2.087e-11
99 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 9 154 4.581e-13 2.153e-11
100 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 9 162 7.264e-13 3.346e-11
101 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 9 162 7.264e-13 3.346e-11
102 MORPHOGENESIS OF A BRANCHING STRUCTURE 9 167 9.574e-13 4.368e-11
103 EPITHELIAL CELL DIFFERENTIATION 12 495 9.829e-13 4.44e-11
104 NEURON DIFFERENTIATION 14 874 1.895e-12 8.478e-11
105 POSITIVE REGULATION OF STEM CELL PROLIFERATION 7 61 1.937e-12 8.585e-11
106 REGULATION OF HEART MORPHOGENESIS 6 29 1.972e-12 8.587e-11
107 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 8 111 1.975e-12 8.587e-11
108 REGULATION OF OSTEOBLAST DIFFERENTIATION 8 112 2.125e-12 9.153e-11
109 ANTERIOR POSTERIOR PATTERN SPECIFICATION 9 194 3.717e-12 1.572e-10
110 GROWTH 11 410 3.693e-12 1.572e-10
111 NEUROGENESIS 16 1402 4.252e-12 1.758e-10
112 RESPIRATORY SYSTEM DEVELOPMENT 9 197 4.269e-12 1.758e-10
113 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 9 197 4.269e-12 1.758e-10
114 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 13 740 4.921e-12 2.008e-10
115 KIDNEY EPITHELIUM DEVELOPMENT 8 125 5.195e-12 2.102e-10
116 SKIN EPIDERMIS DEVELOPMENT 7 71 5.852e-12 2.347e-10
117 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 9 207 6.669e-12 2.652e-10
118 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 8 131 7.599e-12 2.996e-10
119 SKIN DEVELOPMENT 9 211 7.923e-12 3.098e-10
120 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 5 16 1.594e-11 6.18e-10
121 REGULATION OF CELL ADHESION 12 629 1.62e-11 6.23e-10
122 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 9 229 1.652e-11 6.302e-10
123 REGULATION OF GROWTH 12 633 1.744e-11 6.598e-10
124 HAIR CYCLE 7 83 1.807e-11 6.726e-10
125 MOLTING CYCLE 7 83 1.807e-11 6.726e-10
126 PROSTATE GLAND DEVELOPMENT 6 41 1.845e-11 6.814e-10
127 FOREBRAIN DEVELOPMENT 10 357 2.857e-11 1.047e-09
128 MESONEPHROS DEVELOPMENT 7 90 3.23e-11 1.174e-09
129 BLOOD VESSEL MORPHOGENESIS 10 364 3.458e-11 1.247e-09
130 OSSIFICATION 9 251 3.754e-11 1.344e-09
131 POSITIVE REGULATION OF RESPONSE TO STIMULUS 17 1929 3.85e-11 1.368e-09
132 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 16 1656 5.301e-11 1.869e-09
133 GLAND MORPHOGENESIS 7 97 5.519e-11 1.931e-09
134 REGULATION OF PROTEIN BINDING 8 168 5.648e-11 1.961e-09
135 APPENDAGE DEVELOPMENT 8 169 5.923e-11 2.026e-09
136 LIMB DEVELOPMENT 8 169 5.923e-11 2.026e-09
137 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 7 100 6.858e-11 2.329e-09
138 REGULATION OF MUSCLE TISSUE DEVELOPMENT 7 103 8.465e-11 2.834e-09
139 REGULATION OF MUSCLE ORGAN DEVELOPMENT 7 103 8.465e-11 2.834e-09
140 CARDIAC CHAMBER MORPHOGENESIS 7 104 9.067e-11 2.971e-09
141 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 7 104 9.067e-11 2.971e-09
142 REGULATION OF CELL MORPHOGENESIS 11 552 9.001e-11 2.971e-09
143 CARDIAC VENTRICLE DEVELOPMENT 7 106 1.038e-10 3.378e-09
144 CARDIAC MUSCLE TISSUE MORPHOGENESIS 6 54 1.047e-10 3.383e-09
145 ANGIOGENESIS 9 293 1.488e-10 4.775e-09
146 REGULATION OF CELLULAR COMPONENT BIOGENESIS 12 767 1.607e-10 5.121e-09
147 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 7 115 1.851e-10 5.781e-09
148 MUSCLE STRUCTURE DEVELOPMENT 10 432 1.848e-10 5.781e-09
149 NEPHRON DEVELOPMENT 7 115 1.851e-10 5.781e-09
150 STEM CELL PROLIFERATION 6 60 2.018e-10 6.26e-09
151 POSITIVE REGULATION OF CELL DEATH 11 605 2.386e-10 7.353e-09
152 POSITIVE REGULATION OF CELL COMMUNICATION 15 1532 2.472e-10 7.568e-09
153 RESPONSE TO OXYGEN LEVELS 9 311 2.524e-10 7.675e-09
154 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 7 122 2.812e-10 8.449e-09
155 RESPONSE TO ABIOTIC STIMULUS 13 1024 2.815e-10 8.449e-09
156 AXIS ELONGATION 5 27 2.915e-10 8.693e-09
157 ENDOCRINE SYSTEM DEVELOPMENT 7 123 2.979e-10 8.829e-09
158 REPRODUCTION 14 1297 3.685e-10 1.085e-08
159 VASCULATURE DEVELOPMENT 10 469 4.109e-10 1.203e-08
160 REGULATION OF REPRODUCTIVE PROCESS 7 129 4.169e-10 1.212e-08
161 EPIDERMIS MORPHOGENESIS 5 29 4.279e-10 1.237e-08
162 DEVELOPMENTAL GROWTH 9 333 4.616e-10 1.326e-08
163 MUSCLE ORGAN MORPHOGENESIS 6 70 5.235e-10 1.494e-08
164 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 7 134 5.449e-10 1.546e-08
165 REGULATION OF ORGAN FORMATION 5 32 7.236e-10 2.04e-08
166 CARDIAC MUSCLE TISSUE DEVELOPMENT 7 140 7.415e-10 2.078e-08
167 RESPONSE TO LIPID 12 888 8.596e-10 2.395e-08
168 CARDIAC CHAMBER DEVELOPMENT 7 144 9.037e-10 2.488e-08
169 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 7 144 9.037e-10 2.488e-08
170 SENSORY ORGAN MORPHOGENESIS 8 239 9.355e-10 2.56e-08
171 REGULATION OF CELLULAR RESPONSE TO STRESS 11 691 9.722e-10 2.645e-08
172 REGULATION OF APOPTOTIC SIGNALING PATHWAY 9 363 9.866e-10 2.669e-08
173 REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 34 9.979e-10 2.684e-08
174 RENAL TUBULE DEVELOPMENT 6 78 1.018e-09 2.691e-08
175 EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 4 11 1.007e-09 2.691e-08
176 SOMITE DEVELOPMENT 6 78 1.018e-09 2.691e-08
177 HEAD DEVELOPMENT 11 709 1.274e-09 3.349e-08
178 AMEBOIDAL TYPE CELL MIGRATION 7 154 1.447e-09 3.782e-08
179 EPIDERMIS DEVELOPMENT 8 253 1.466e-09 3.812e-08
180 EMBRYONIC PLACENTA DEVELOPMENT 6 83 1.489e-09 3.848e-08
181 POSITIVE REGULATION OF OSSIFICATION 6 84 1.602e-09 4.117e-08
182 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 4 13 2.178e-09 5.537e-08
183 MESENCHYMAL CELL PROLIFERATION 4 13 2.178e-09 5.537e-08
184 MUSCLE TISSUE DEVELOPMENT 8 275 2.827e-09 7.148e-08
185 NEPHRON EPITHELIUM DEVELOPMENT 6 93 2.978e-09 7.49e-08
186 CANONICAL WNT SIGNALING PATHWAY 6 95 3.389e-09 8.478e-08
187 ENDOCARDIAL CUSHION FORMATION 4 15 4.149e-09 1.027e-07
188 REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 4 15 4.149e-09 1.027e-07
189 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 12 1036 4.93e-09 1.195e-07
190 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 12 1036 4.93e-09 1.195e-07
191 REGULATION OF CHONDROCYTE DIFFERENTIATION 5 46 4.859e-09 1.195e-07
192 CAMERA TYPE EYE MORPHOGENESIS 6 101 4.914e-09 1.195e-07
193 PARAXIAL MESODERM DEVELOPMENT 4 16 5.527e-09 1.333e-07
194 NEGATIVE REGULATION OF CELL DEVELOPMENT 8 303 6.045e-09 1.446e-07
195 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 5 48 6.059e-09 1.446e-07
196 ODONTOGENESIS 6 105 6.217e-09 1.476e-07
197 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 7 190 6.253e-09 1.477e-07
198 REGULATION OF PHOSPHORUS METABOLIC PROCESS 14 1618 6.603e-09 1.552e-07
199 EAR DEVELOPMENT 7 195 7.486e-09 1.75e-07
200 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 7 200 8.921e-09 2.076e-07
201 NOTOCHORD DEVELOPMENT 4 18 9.275e-09 2.137e-07
202 SKELETAL SYSTEM MORPHOGENESIS 7 201 9.235e-09 2.137e-07
203 MESONEPHRIC TUBULE MORPHOGENESIS 5 53 1.011e-08 2.316e-07
204 NOTCH SIGNALING PATHWAY 6 114 1.021e-08 2.33e-07
205 EYE DEVELOPMENT 8 326 1.07e-08 2.429e-07
206 REGULATION OF MAPK CASCADE 10 660 1.097e-08 2.478e-07
207 CENTRAL NERVOUS SYSTEM DEVELOPMENT 11 872 1.104e-08 2.483e-07
208 OUTFLOW TRACT MORPHOGENESIS 5 56 1.341e-08 2.997e-07
209 REGULATION OF PROTEIN MODIFICATION PROCESS 14 1710 1.346e-08 2.997e-07
210 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 12 1135 1.373e-08 3.042e-07
211 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 4 20 1.466e-08 3.232e-07
212 EMBRYONIC PATTERN SPECIFICATION 5 58 1.606e-08 3.524e-07
213 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 10 689 1.651e-08 3.606e-07
214 OSTEOBLAST DIFFERENTIATION 6 126 1.865e-08 4.055e-07
215 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 5 60 1.91e-08 4.134e-07
216 POSITIVE REGULATION OF BINDING 6 127 1.956e-08 4.213e-07
217 TUBE FORMATION 6 129 2.148e-08 4.606e-07
218 SOMATIC STEM CELL DIVISION 4 22 2.209e-08 4.714e-07
219 CARDIAC VENTRICLE MORPHOGENESIS 5 62 2.259e-08 4.8e-07
220 NEUROEPITHELIAL CELL DIFFERENTIATION 5 63 2.451e-08 5.185e-07
221 PROTEIN PHOSPHORYLATION 11 944 2.506e-08 5.276e-07
222 REGULATION OF CELL CYCLE 11 949 2.646e-08 5.546e-07
223 PROSTATE GLAND MORPHOGENESIS 4 23 2.671e-08 5.574e-07
224 MUSCLE CELL DIFFERENTIATION 7 237 2.876e-08 5.975e-07
225 POSITIVE REGULATION OF GROWTH 7 238 2.961e-08 6.096e-07
226 EYE MORPHOGENESIS 6 136 2.948e-08 6.096e-07
227 RESPONSE TO EXTERNAL STIMULUS 14 1821 3.012e-08 6.174e-07
228 PLACENTA DEVELOPMENT 6 138 3.217e-08 6.565e-07
229 ORGAN GROWTH 5 68 3.618e-08 7.352e-07
230 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 10 750 3.682e-08 7.45e-07
231 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 25 3.809e-08 7.672e-07
232 NEGATIVE REGULATION OF OSSIFICATION 5 69 3.897e-08 7.816e-07
233 ENDODERM DEVELOPMENT 5 71 4.506e-08 8.961e-07
234 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 4 26 4.497e-08 8.961e-07
235 EMBRYONIC HEART TUBE DEVELOPMENT 5 73 5.189e-08 1.027e-06
236 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 27 5.274e-08 1.035e-06
237 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 4 27 5.274e-08 1.035e-06
238 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 7 262 5.72e-08 1.115e-06
239 REGULATION OF MUSCLE CELL DIFFERENTIATION 6 152 5.727e-08 1.115e-06
240 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 8 406 5.863e-08 1.137e-06
241 IMMUNE SYSTEM DEVELOPMENT 9 582 5.928e-08 1.144e-06
242 VENTRICULAR SEPTUM MORPHOGENESIS 4 28 6.147e-08 1.182e-06
243 DIENCEPHALON DEVELOPMENT 5 77 6.799e-08 1.302e-06
244 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 29 7.124e-08 1.347e-06
245 STEM CELL DIVISION 4 29 7.124e-08 1.347e-06
246 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 4 29 7.124e-08 1.347e-06
247 KIDNEY MORPHOGENESIS 5 82 9.344e-08 1.76e-06
248 REGULATION OF EPITHELIAL CELL MIGRATION 6 166 9.671e-08 1.814e-06
249 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 8 437 1.032e-07 1.929e-06
250 ORGAN FORMATION 4 34 1.384e-07 2.566e-06
251 HEART VALVE DEVELOPMENT 4 34 1.384e-07 2.566e-06
252 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 10 876 1.578e-07 2.914e-06
253 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 5 93 1.761e-07 3.239e-06
254 RESPONSE TO BMP 5 94 1.858e-07 3.391e-06
255 CELLULAR RESPONSE TO BMP STIMULUS 5 94 1.858e-07 3.391e-06
256 EPITHELIAL CELL DEVELOPMENT 6 186 1.897e-07 3.447e-06
257 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 4 37 1.966e-07 3.559e-06
258 POSITIVE REGULATION OF MOLECULAR FUNCTION 13 1791 2.361e-07 4.258e-06
259 RESPONSE TO ORGANIC CYCLIC COMPOUND 10 917 2.414e-07 4.336e-06
260 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 4 39 2.443e-07 4.356e-06
261 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 4 39 2.443e-07 4.356e-06
262 RESPONSE TO STEROID HORMONE 8 497 2.758e-07 4.898e-06
263 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 12 1492 2.804e-07 4.943e-06
264 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 5 102 2.798e-07 4.943e-06
265 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 5 103 2.938e-07 5.159e-06
266 PITUITARY GLAND DEVELOPMENT 4 42 3.315e-07 5.778e-06
267 REGULATION OF HEART GROWTH 4 42 3.315e-07 5.778e-06
268 REGULATION OF PROTEIN LOCALIZATION 10 950 3.348e-07 5.813e-06
269 PHOSPHORYLATION 11 1228 3.638e-07 6.292e-06
270 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 3 11 4.024e-07 6.935e-06
271 LUNG MORPHOGENESIS 4 45 4.401e-07 7.5e-06
272 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 4 45 4.401e-07 7.5e-06
273 EXOCRINE SYSTEM DEVELOPMENT 4 45 4.401e-07 7.5e-06
274 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 6 218 4.827e-07 8.197e-06
275 REGULATION OF EMBRYONIC DEVELOPMENT 5 114 4.875e-07 8.249e-06
276 REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS 3 12 5.361e-07 9.038e-06
277 MAMMARY GLAND DEVELOPMENT 5 117 5.548e-07 9.32e-06
278 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 7 368 5.724e-07 9.557e-06
279 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 4 48 5.73e-07 9.557e-06
280 REGULATION OF CELLULAR PROTEIN LOCALIZATION 8 552 6.111e-07 1.016e-05
281 CARDIAC SEPTUM MORPHOGENESIS 4 49 6.234e-07 1.032e-05
282 REGULATION OF NEURON DIFFERENTIATION 8 554 6.28e-07 1.033e-05
283 TELENCEPHALON DEVELOPMENT 6 228 6.277e-07 1.033e-05
284 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 5 121 6.558e-07 1.074e-05
285 POSITIVE REGULATION OF CELL ADHESION 7 376 6.613e-07 1.08e-05
286 FACE DEVELOPMENT 4 50 6.769e-07 1.101e-05
287 CARDIOBLAST DIFFERENTIATION 3 13 6.962e-07 1.129e-05
288 REGULATION OF CYTOKINE PRODUCTION 8 563 7.092e-07 1.143e-05
289 REGULATION OF CELL CELL ADHESION 7 380 7.099e-07 1.143e-05
290 REGULATION OF VASCULATURE DEVELOPMENT 6 233 7.126e-07 1.143e-05
291 ARTERY MORPHOGENESIS 4 51 7.338e-07 1.173e-05
292 HEPATICOBILIARY SYSTEM DEVELOPMENT 5 128 8.669e-07 1.381e-05
293 CELL MIGRATION INVOLVED IN GASTRULATION 3 14 8.853e-07 1.396e-05
294 EMBRYONIC SKELETAL JOINT DEVELOPMENT 3 14 8.853e-07 1.396e-05
295 CONVERGENT EXTENSION 3 14 8.853e-07 1.396e-05
296 VENTRICULAR SEPTUM DEVELOPMENT 4 54 9.26e-07 1.456e-05
297 NEGATIVE REGULATION OF BINDING 5 131 9.723e-07 1.523e-05
298 REGULATION OF KIDNEY DEVELOPMENT 4 55 9.977e-07 1.558e-05
299 MAINTENANCE OF CELL NUMBER 5 132 1.01e-06 1.571e-05
300 NEURON PROJECTION MORPHOGENESIS 7 402 1.034e-06 1.605e-05
301 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 4 56 1.073e-06 1.659e-05
302 MORPHOGENESIS OF AN EPITHELIAL FOLD 3 15 1.106e-06 1.698e-05
303 STRIATED MUSCLE CELL PROLIFERATION 3 15 1.106e-06 1.698e-05
304 RESPONSE TO OXYGEN CONTAINING COMPOUND 11 1381 1.173e-06 1.795e-05
305 REGULATION OF GLIAL CELL DIFFERENTIATION 4 59 1.326e-06 2.023e-05
306 MORPHOGENESIS OF AN ENDOTHELIUM 3 16 1.359e-06 2.067e-05
307 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 4 60 1.42e-06 2.152e-05
308 EMBRYONIC DIGIT MORPHOGENESIS 4 61 1.518e-06 2.293e-05
309 SOMITOGENESIS 4 62 1.621e-06 2.441e-05
310 BRANCH ELONGATION OF AN EPITHELIUM 3 17 1.649e-06 2.46e-05
311 NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 3 17 1.649e-06 2.46e-05
312 NEGATIVE REGULATION OF STEM CELL PROLIFERATION 3 17 1.649e-06 2.46e-05
313 RESPONSE TO ESTRADIOL 5 146 1.661e-06 2.47e-05
314 MUSCLE ORGAN DEVELOPMENT 6 277 1.95e-06 2.889e-05
315 PERICARDIUM DEVELOPMENT 3 18 1.977e-06 2.911e-05
316 NEPHRON TUBULE FORMATION 3 18 1.977e-06 2.911e-05
317 ACTIVATION OF PROTEIN KINASE ACTIVITY 6 279 2.033e-06 2.984e-05
318 REGULATION OF RESPONSE TO STRESS 11 1468 2.143e-06 3.135e-05
319 RESPONSE TO HORMONE 9 893 2.173e-06 3.169e-05
320 NEURON FATE COMMITMENT 4 67 2.216e-06 3.223e-05
321 REGULATION OF CELL JUNCTION ASSEMBLY 4 68 2.353e-06 3.379e-05
322 MUSCLE CELL PROLIFERATION 3 19 2.346e-06 3.379e-05
323 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 3 19 2.346e-06 3.379e-05
324 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 4 68 2.353e-06 3.379e-05
325 REGULATION OF ORGANELLE ORGANIZATION 10 1178 2.391e-06 3.423e-05
326 CELLULAR RESPONSE TO LIPID 7 457 2.427e-06 3.464e-05
327 REGULATION OF DEVELOPMENTAL GROWTH 6 289 2.492e-06 3.546e-05
328 TRACHEA DEVELOPMENT 3 20 2.757e-06 3.911e-05
329 CELL FATE SPECIFICATION 4 71 2.799e-06 3.959e-05
330 POSITIVE REGULATION OF MAPK CASCADE 7 470 2.922e-06 4.12e-05
331 POSITIVE REGULATION OF CATALYTIC ACTIVITY 11 1518 2.975e-06 4.182e-05
332 POSITIVE REGULATION OF PROTEIN BINDING 4 73 3.129e-06 4.36e-05
333 REGULATION OF ORGAN GROWTH 4 73 3.129e-06 4.36e-05
334 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 4 73 3.129e-06 4.36e-05
335 POSITIVE REGULATION OF NEUROBLAST PROLIFERATION 3 21 3.214e-06 4.45e-05
336 LEFT RIGHT PATTERN FORMATION 3 21 3.214e-06 4.45e-05
337 REGULATION OF TRANSFERASE ACTIVITY 9 946 3.491e-06 4.764e-05
338 ARTERY DEVELOPMENT 4 75 3.488e-06 4.764e-05
339 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 4 75 3.488e-06 4.764e-05
340 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 4 75 3.488e-06 4.764e-05
341 NEURAL CREST CELL DIFFERENTIATION 4 75 3.488e-06 4.764e-05
342 EMBRYONIC PLACENTA MORPHOGENESIS 3 22 3.718e-06 5.058e-05
343 REGULATION OF BMP SIGNALING PATHWAY 4 77 3.876e-06 5.258e-05
344 GLIOGENESIS 5 175 4.044e-06 5.47e-05
345 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS 3 23 4.271e-06 5.76e-05
346 NEGATIVE REGULATION OF PROTEIN BINDING 4 79 4.295e-06 5.776e-05
347 RESPONSE TO ACID CHEMICAL 6 319 4.402e-06 5.886e-05
348 REGULATION OF MAP KINASE ACTIVITY 6 319 4.402e-06 5.886e-05
349 CELLULAR RESPONSE TO MECHANICAL STIMULUS 4 80 4.517e-06 6.022e-05
350 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 8 724 4.634e-06 6.16e-05
351 NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 3 24 4.877e-06 6.446e-05
352 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 3 24 4.877e-06 6.446e-05
353 REGULATION OF CELLULAR LOCALIZATION 10 1277 4.936e-06 6.506e-05
354 REGULATION OF PROTEIN IMPORT 5 183 5.031e-06 6.612e-05
355 ORGAN REGENERATION 4 83 5.233e-06 6.859e-05
356 CELL JUNCTION ORGANIZATION 5 185 5.305e-06 6.933e-05
357 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 3 25 5.537e-06 7.136e-05
358 LUNG CELL DIFFERENTIATION 3 25 5.537e-06 7.136e-05
359 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 3 25 5.537e-06 7.136e-05
360 POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 3 25 5.537e-06 7.136e-05
361 POSITIVE REGULATION OF CELL CYCLE 6 332 5.536e-06 7.136e-05
362 RESPONSE TO METAL ION 6 333 5.632e-06 7.239e-05
363 CARDIAC SEPTUM DEVELOPMENT 4 85 5.755e-06 7.377e-05
364 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 5 191 6.197e-06 7.922e-05
365 HEART TRABECULA MORPHOGENESIS 3 26 6.253e-06 7.928e-05
366 NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION 3 26 6.253e-06 7.928e-05
367 HEART GROWTH 3 26 6.253e-06 7.928e-05
368 TISSUE REMODELING 4 87 6.314e-06 7.984e-05
369 DEVELOPMENTAL MATURATION 5 193 6.52e-06 8.221e-05
370 SEGMENTATION 4 89 6.913e-06 8.67e-05
371 EPITHELIAL CELL PROLIFERATION 4 89 6.913e-06 8.67e-05
372 POSITIVE REGULATION OF HEART GROWTH 3 27 7.028e-06 8.72e-05
373 DEVELOPMENTAL INDUCTION 3 27 7.028e-06 8.72e-05
374 REGULATION OF ASTROCYTE DIFFERENTIATION 3 27 7.028e-06 8.72e-05
375 RESPONSE TO LITHIUM ION 3 27 7.028e-06 8.72e-05
376 CELL CELL SIGNALING 8 767 7.085e-06 8.767e-05
377 AXIS SPECIFICATION 4 90 7.227e-06 8.897e-05
378 REGULATION OF GLIOGENESIS 4 90 7.227e-06 8.897e-05
379 WNT SIGNALING PATHWAY 6 351 7.611e-06 9.344e-05
380 REGULATION OF KINASE ACTIVITY 8 776 7.717e-06 9.437e-05
381 NEURON PROJECTION DEVELOPMENT 7 545 7.728e-06 9.437e-05
382 REGULATION OF NEUROBLAST PROLIFERATION 3 28 7.864e-06 9.554e-05
383 DOPAMINERGIC NEURON DIFFERENTIATION 3 28 7.864e-06 9.554e-05
384 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 3 29 8.763e-06 0.0001059
385 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 3 29 8.763e-06 0.0001059
386 REGULATION OF CELL CYCLE PROCESS 7 558 9.012e-06 0.0001086
387 RESPONSE TO ALCOHOL 6 362 9.075e-06 0.0001091
388 CARDIOCYTE DIFFERENTIATION 4 96 9.342e-06 0.000112
389 SMOOTH MUSCLE CELL DIFFERENTIATION 3 30 9.727e-06 0.0001164
390 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 4 98 1.014e-05 0.000121
391 NEGATIVE REGULATION OF MOLECULAR FUNCTION 9 1079 1.018e-05 0.0001212
392 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 7 573 1.071e-05 0.0001271
393 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 4 100 1.099e-05 0.0001301
394 RESPONSE TO ESTROGEN 5 218 1.177e-05 0.000139
395 SALIVARY GLAND DEVELOPMENT 3 32 1.186e-05 0.0001394
396 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA 3 32 1.186e-05 0.0001394
397 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 5 220 1.23e-05 0.0001442
398 EMBRYONIC AXIS SPECIFICATION 3 33 1.304e-05 0.0001513
399 REGULATION OF T CELL APOPTOTIC PROCESS 3 33 1.304e-05 0.0001513
400 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 3 33 1.304e-05 0.0001513
401 EMBRYONIC EYE MORPHOGENESIS 3 33 1.304e-05 0.0001513
402 NEGATIVE REGULATION OF CELL ADHESION 5 223 1.314e-05 0.0001521
403 REGULATION OF CELL GROWTH 6 391 1.406e-05 0.0001624
404 HAIR CELL DIFFERENTIATION 3 35 1.561e-05 0.0001793
405 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 3 35 1.561e-05 0.0001793
406 PROTEIN LOCALIZATION 11 1805 1.582e-05 0.0001813
407 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 3 36 1.701e-05 0.0001935
408 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 3 36 1.701e-05 0.0001935
409 HEAD MORPHOGENESIS 3 36 1.701e-05 0.0001935
410 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 7 616 1.712e-05 0.0001943
411 EAR MORPHOGENESIS 4 112 1.72e-05 0.0001947
412 NEGATIVE REGULATION OF GROWTH 5 236 1.727e-05 0.000195
413 NEGATIVE REGULATION OF GLIOGENESIS 3 37 1.849e-05 0.0002074
414 MYOBLAST DIFFERENTIATION 3 37 1.849e-05 0.0002074
415 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 3 37 1.849e-05 0.0002074
416 RESPONSE TO FIBROBLAST GROWTH FACTOR 4 116 1.975e-05 0.0002209
417 COLLAGEN FIBRIL ORGANIZATION 3 38 2.006e-05 0.0002228
418 BONE MINERALIZATION 3 38 2.006e-05 0.0002228
419 POSITIVE REGULATION OF ORGAN GROWTH 3 38 2.006e-05 0.0002228
420 CELL PART MORPHOGENESIS 7 633 2.04e-05 0.0002258
421 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 4 117 2.043e-05 0.0002258
422 ANATOMICAL STRUCTURE MATURATION 3 39 2.171e-05 0.0002388
423 TRABECULA MORPHOGENESIS 3 39 2.171e-05 0.0002388
424 CYTOKINE PRODUCTION 4 120 2.258e-05 0.0002477
425 POSITIVE REGULATION OF CELL MATRIX ADHESION 3 40 2.345e-05 0.0002567
426 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 4 122 2.409e-05 0.0002631
427 NEGATIVE REGULATION OF CELL CYCLE 6 433 2.501e-05 0.0002726
428 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 6 437 2.634e-05 0.0002863
429 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 3 42 2.72e-05 0.0002936
430 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 3 42 2.72e-05 0.0002936
431 GENITALIA DEVELOPMENT 3 42 2.72e-05 0.0002936
432 NEGATIVE REGULATION OF LOCOMOTION 5 263 2.904e-05 0.0003121
433 CELLULAR RESPONSE TO ABIOTIC STIMULUS 5 263 2.904e-05 0.0003121
434 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 3 43 2.921e-05 0.0003132
435 SEX DIFFERENTIATION 5 266 3.066e-05 0.000328
436 LABYRINTHINE LAYER DEVELOPMENT 3 44 3.132e-05 0.0003319
437 BODY MORPHOGENESIS 3 44 3.132e-05 0.0003319
438 NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 3 44 3.132e-05 0.0003319
439 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 3 44 3.132e-05 0.0003319
440 SPROUTING ANGIOGENESIS 3 45 3.352e-05 0.0003537
441 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 3 45 3.352e-05 0.0003537
442 NEURON DEVELOPMENT 7 687 3.449e-05 0.0003631
443 CELL DIVISION 6 460 3.511e-05 0.0003688
444 CELL GROWTH 4 135 3.585e-05 0.0003748
445 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 3 46 3.583e-05 0.0003748
446 TAXIS 6 464 3.686e-05 0.0003841
447 GLIAL CELL DIFFERENTIATION 4 136 3.69e-05 0.0003841
448 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 6 465 3.73e-05 0.000387
449 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 11 1977 3.735e-05 0.000387
450 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 3 47 3.824e-05 0.0003954
451 IMMUNE SYSTEM PROCESS 11 1984 3.86e-05 0.0003982
452 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 4 138 3.907e-05 0.0004013
453 NEGATIVE REGULATION OF CELL CELL ADHESION 4 138 3.907e-05 0.0004013
454 WOUND HEALING 6 470 3.96e-05 0.000405
455 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 6 470 3.96e-05 0.000405
456 ANTERIOR POSTERIOR AXIS SPECIFICATION 3 48 4.075e-05 0.0004158
457 NON CANONICAL WNT SIGNALING PATHWAY 4 140 4.133e-05 0.0004208
458 REGULATION OF STEROID BIOSYNTHETIC PROCESS 3 49 4.336e-05 0.0004405
459 EPIDERMAL CELL DIFFERENTIATION 4 142 4.368e-05 0.0004428
460 RESPONSE TO INORGANIC SUBSTANCE 6 479 4.402e-05 0.0004453
461 CELLULAR RESPONSE TO OXYGEN LEVELS 4 143 4.49e-05 0.0004532
462 POSITIVE REGULATION OF KINASE ACTIVITY 6 482 4.558e-05 0.000459
463 ENDODERM FORMATION 3 50 4.609e-05 0.0004632
464 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 4 145 4.74e-05 0.0004753
465 POSITIVE REGULATION OF CELL GROWTH 4 148 5.134e-05 0.0005126
466 MALE SEX DIFFERENTIATION 4 148 5.134e-05 0.0005126
467 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 3 52 5.187e-05 0.0005157
468 NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 3 52 5.187e-05 0.0005157
469 NEURAL TUBE DEVELOPMENT 4 149 5.271e-05 0.0005229
470 REGULATION OF HYDROLASE ACTIVITY 9 1327 5.285e-05 0.0005232
471 MAMMARY GLAND EPITHELIUM DEVELOPMENT 3 53 5.493e-05 0.0005427
472 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 4 152 5.696e-05 0.0005608
473 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 5 303 5.701e-05 0.0005608
474 NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 3 54 5.811e-05 0.000568
475 REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 3 54 5.811e-05 0.000568
476 EXTRACELLULAR STRUCTURE ORGANIZATION 5 304 5.791e-05 0.000568
477 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 4 153 5.843e-05 0.0005688
478 PALLIUM DEVELOPMENT 4 153 5.843e-05 0.0005688
479 POSITIVE REGULATION OF NEURON DIFFERENTIATION 5 306 5.974e-05 0.0005803
480 REGULATION OF PROTEIN TARGETING 5 307 6.067e-05 0.0005881
481 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 3 55 6.14e-05 0.0005927
482 CRANIAL SKELETAL SYSTEM DEVELOPMENT 3 55 6.14e-05 0.0005927
483 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 4 156 6.302e-05 0.0006046
484 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 4 156 6.302e-05 0.0006046
485 PROTEIN LOCALIZATION TO NUCLEUS 4 156 6.302e-05 0.0006046
486 SMAD PROTEIN SIGNAL TRANSDUCTION 3 56 6.482e-05 0.0006206
487 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 6 514 6.514e-05 0.0006224
488 POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 3 57 6.835e-05 0.0006517
489 MULTICELLULAR ORGANISM REPRODUCTION 7 768 6.998e-05 0.0006659
490 REGENERATION 4 161 7.124e-05 0.0006765
491 POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 3 59 7.58e-05 0.0007183
492 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 3 60 7.972e-05 0.0007524
493 CHONDROCYTE DIFFERENTIATION 3 60 7.972e-05 0.0007524
494 REGULATION OF VIRAL TRANSCRIPTION 3 61 8.376e-05 0.0007889
495 CHROMATIN MODIFICATION 6 539 8.469e-05 0.0007961
496 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 3 62 8.794e-05 0.0008233
497 EMBRYONIC HEART TUBE MORPHOGENESIS 3 62 8.794e-05 0.0008233
498 REGULATION OF CELL SUBSTRATE ADHESION 4 173 9.413e-05 0.0008795
499 CELLULAR RESPONSE TO ACID CHEMICAL 4 175 9.841e-05 0.0009158
500 REGULATION OF DNA METABOLIC PROCESS 5 340 9.823e-05 0.0009158
501 REGULATION OF TRANSPORT 10 1804 9.984e-05 0.0009273
502 PROTEIN LOCALIZATION TO ORGANELLE 6 556 0.0001005 0.0009313
503 CELLULAR RESPONSE TO RETINOIC ACID 3 65 0.0001013 0.0009332
504 REGULATION OF CHEMOKINE PRODUCTION 3 65 0.0001013 0.0009332
505 REGULATION OF RESPONSE TO OXIDATIVE STRESS 3 65 0.0001013 0.0009332
506 ENDOCARDIUM DEVELOPMENT 2 11 0.0001031 0.0009374
507 REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 2 11 0.0001031 0.0009374
508 RESPONSE TO FOLLICLE STIMULATING HORMONE 2 11 0.0001031 0.0009374
509 PROSTATE GLAND GROWTH 2 11 0.0001031 0.0009374
510 VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS 2 11 0.0001031 0.0009374
511 PROSTATE GLANDULAR ACINUS DEVELOPMENT 2 11 0.0001031 0.0009374
512 ENDOTHELIAL TUBE MORPHOGENESIS 2 11 0.0001031 0.0009374
513 SOMATIC STEM CELL POPULATION MAINTENANCE 3 66 0.000106 0.0009577
514 FOREBRAIN GENERATION OF NEURONS 3 66 0.000106 0.0009577
515 LENS DEVELOPMENT IN CAMERA TYPE EYE 3 66 0.000106 0.0009577
516 RESPONSE TO WOUNDING 6 563 0.0001076 0.0009705
517 POSITIVE REGULATION OF NEURON DEATH 3 67 0.0001109 0.0009959
518 REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS 3 67 0.0001109 0.0009959
519 RESPONSE TO ACTIVITY 3 69 0.000121 0.001085
520 CARDIAC LEFT VENTRICLE MORPHOGENESIS 2 12 0.0001237 0.001088
521 REGULATION OF TIMING OF CELL DIFFERENTIATION 2 12 0.0001237 0.001088
522 POSITIVE REGULATION OF DNA METABOLIC PROCESS 4 185 0.000122 0.001088
523 CARTILAGE MORPHOGENESIS 2 12 0.0001237 0.001088
524 REGULATION OF VITAMIN METABOLIC PROCESS 2 12 0.0001237 0.001088
525 REGULATION OF THYMOCYTE APOPTOTIC PROCESS 2 12 0.0001237 0.001088
526 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 2 12 0.0001237 0.001088
527 REGULATION OF DEVELOPMENT HETEROCHRONIC 2 12 0.0001237 0.001088
528 POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION 2 12 0.0001237 0.001088
529 NEGATIVE REGULATION OF RECEPTOR BINDING 2 12 0.0001237 0.001088
530 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 3 71 0.0001318 0.001157
531 MYELOID CELL DIFFERENTIATION 4 189 0.0001324 0.001161
532 ENDOTHELIAL CELL DIFFERENTIATION 3 72 0.0001374 0.001202
533 REGULATION OF NEURON APOPTOTIC PROCESS 4 192 0.0001407 0.001228
534 NEURONAL STEM CELL DIVISION 2 13 0.000146 0.001247
535 NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 2 13 0.000146 0.001247
536 PANCREAS DEVELOPMENT 3 73 0.0001431 0.001247
537 LEFT RIGHT AXIS SPECIFICATION 2 13 0.000146 0.001247
538 CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS 2 13 0.000146 0.001247
539 HEART VALVE FORMATION 2 13 0.000146 0.001247
540 RESPONSE TO HEPATOCYTE GROWTH FACTOR 2 13 0.000146 0.001247
541 POSITIVE REGULATION OF CYTOKINE PRODUCTION 5 370 0.000146 0.001247
542 NEUROBLAST DIVISION 2 13 0.000146 0.001247
543 GLIAL CELL FATE COMMITMENT 2 13 0.000146 0.001247
544 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 2 13 0.000146 0.001247
545 NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 2 13 0.000146 0.001247
546 REGULATION OF STEROID METABOLIC PROCESS 3 74 0.000149 0.00127
547 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 4 197 0.0001553 0.001319
548 BIOMINERAL TISSUE DEVELOPMENT 3 75 0.0001551 0.001319
549 PROTEIN COMPLEX SUBUNIT ORGANIZATION 9 1527 0.0001567 0.001328
550 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 5 381 0.0001674 0.001416
551 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 2 14 0.0001702 0.001427
552 SPECIFICATION OF ORGAN IDENTITY 2 14 0.0001702 0.001427
553 REGULATION OF GLOMERULUS DEVELOPMENT 2 14 0.0001702 0.001427
554 REGULATION OF PROTEIN KINASE C SIGNALING 2 14 0.0001702 0.001427
555 MIDGUT DEVELOPMENT 2 14 0.0001702 0.001427
556 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 6 616 0.0001759 0.001472
557 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 3 79 0.000181 0.001506
558 REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 4 205 0.000181 0.001506
559 NEURON PROJECTION GUIDANCE 4 205 0.000181 0.001506
560 NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 3 80 0.0001878 0.001561
561 CELL PROJECTION ORGANIZATION 7 902 0.0001909 0.001584
562 POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 2 15 0.0001962 0.001613
563 METANEPHROS DEVELOPMENT 3 81 0.0001949 0.001613
564 OTIC VESICLE DEVELOPMENT 2 15 0.0001962 0.001613
565 POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS 2 15 0.0001962 0.001613
566 EPITHELIAL CELL FATE COMMITMENT 2 15 0.0001962 0.001613
567 RESPONSE TO MECHANICAL STIMULUS 4 210 0.0001985 0.001629
568 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 4 211 0.0002021 0.001656
569 CELLULAR MACROMOLECULE LOCALIZATION 8 1234 0.0002099 0.001717
570 TISSUE MIGRATION 3 84 0.000217 0.001772
571 RESPONSE TO PEPTIDE 5 404 0.0002198 0.001788
572 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 5 404 0.0002198 0.001788
573 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 3 85 0.0002248 0.001809
574 ORGAN INDUCTION 2 16 0.0002241 0.001809
575 POSITIVE REGULATION OF CHROMATIN MODIFICATION 3 85 0.0002248 0.001809
576 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 2 16 0.0002241 0.001809
577 ATRIOVENTRICULAR VALVE MORPHOGENESIS 2 16 0.0002241 0.001809
578 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 2 16 0.0002241 0.001809
579 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 2 17 0.0002537 0.002015
580 CELLULAR RESPONSE TO LITHIUM ION 2 17 0.0002537 0.002015
581 REGULATION OF RECEPTOR BINDING 2 17 0.0002537 0.002015
582 POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 2 17 0.0002537 0.002015
583 ESTABLISHMENT OF TISSUE POLARITY 2 17 0.0002537 0.002015
584 NEGATIVE REGULATION OF ANOIKIS 2 17 0.0002537 0.002015
585 REGULATION OF STEM CELL POPULATION MAINTENANCE 2 17 0.0002537 0.002015
586 NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 2 17 0.0002537 0.002015
587 CHROMATIN ORGANIZATION 6 663 0.0002619 0.002076
588 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 3 90 0.0002661 0.002095
589 MIDBRAIN DEVELOPMENT 3 90 0.0002661 0.002095
590 ENDOTHELIUM DEVELOPMENT 3 90 0.0002661 0.002095
591 REGULATION OF CELL MATRIX ADHESION 3 90 0.0002661 0.002095
592 INNER EAR MORPHOGENESIS 3 92 0.0002839 0.002231
593 REGULATION OF HORMONE BIOSYNTHETIC PROCESS 2 18 0.0002852 0.002238
594 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 4 232 0.0002902 0.002274
595 REGULATION OF DNA BINDING 3 93 0.0002931 0.002292
596 REGULATION OF DNA BIOSYNTHETIC PROCESS 3 94 0.0003025 0.002357
597 NEURAL TUBE FORMATION 3 94 0.0003025 0.002357
598 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 6 684 0.0003097 0.00241
599 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 3 95 0.000312 0.002416
600 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 3 95 0.000312 0.002416
601 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 3 95 0.000312 0.002416
602 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 2 19 0.0003185 0.002453
603 ATRIOVENTRICULAR VALVE DEVELOPMENT 2 19 0.0003185 0.002453
604 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 2 19 0.0003185 0.002453
605 MYELOID LEUKOCYTE DIFFERENTIATION 3 96 0.0003218 0.002475
606 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 3 98 0.0003419 0.002625
607 POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 2 20 0.0003536 0.002697
608 NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 2 20 0.0003536 0.002697
609 TONGUE DEVELOPMENT 2 20 0.0003536 0.002697
610 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 3 99 0.0003523 0.002697
611 CELL DEATH 7 1001 0.0003613 0.002751
612 LIMBIC SYSTEM DEVELOPMENT 3 100 0.0003628 0.002759
613 POSITIVE REGULATION OF CELL CYCLE PROCESS 4 247 0.0003682 0.002795
614 KERATINOCYTE DIFFERENTIATION 3 101 0.0003736 0.002831
615 ECTODERM DEVELOPMENT 2 21 0.0003904 0.002925
616 CELL AGGREGATION 2 21 0.0003904 0.002925
617 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 2 21 0.0003904 0.002925
618 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 2 21 0.0003904 0.002925
619 COCHLEA MORPHOGENESIS 2 21 0.0003904 0.002925
620 RESPONSE TO CYTOKINE 6 714 0.0003897 0.002925
621 CARTILAGE CONDENSATION 2 21 0.0003904 0.002925
622 REGULATION OF NEURON DEATH 4 252 0.0003972 0.002971
623 CEREBRAL CORTEX DEVELOPMENT 3 105 0.0004187 0.003127
624 REGULATION OF FAT CELL DIFFERENTIATION 3 106 0.0004305 0.003184
625 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 2 22 0.0004291 0.003184
626 MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 2 22 0.0004291 0.003184
627 FAT CELL DIFFERENTIATION 3 106 0.0004305 0.003184
628 PROTEIN LOCALIZATION TO CELL SURFACE 2 22 0.0004291 0.003184
629 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 2 22 0.0004291 0.003184
630 REGULATION OF CATABOLIC PROCESS 6 731 0.0004418 0.003263
631 RESPONSE TO RETINOIC ACID 3 107 0.0004425 0.003263
632 REGULATION OF OSTEOBLAST PROLIFERATION 2 23 0.0004696 0.003457
633 CELLULAR RESPONSE TO EXTERNAL STIMULUS 4 264 0.0004734 0.003475
634 AGING 4 264 0.0004734 0.003475
635 REGULATION OF CYTOPLASMIC TRANSPORT 5 481 0.0004901 0.003591
636 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 2 24 0.0005118 0.003733
637 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 2 24 0.0005118 0.003733
638 REGULATION OF ANOIKIS 2 24 0.0005118 0.003733
639 REGULATION OF CELL DIVISION 4 272 0.0005298 0.003857
640 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 4 274 0.0005445 0.003959
641 CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS 2 25 0.0005558 0.004035
642 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 3 117 0.0005745 0.004152
643 SPECIFICATION OF SYMMETRY 3 117 0.0005745 0.004152
644 CELL CYCLE PROCESS 7 1081 0.0005746 0.004152
645 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 3 118 0.0005889 0.004248
646 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 7 1087 0.000594 0.004278
647 DEVELOPMENTAL PROGRAMMED CELL DEATH 2 26 0.0006016 0.004287
648 NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 2 26 0.0006016 0.004287
649 REGULATION OF MESONEPHROS DEVELOPMENT 2 26 0.0006016 0.004287
650 MESODERMAL CELL DIFFERENTIATION 2 26 0.0006016 0.004287
651 REGULATION OF HORMONE METABOLIC PROCESS 2 26 0.0006016 0.004287
652 REGULATION OF P38MAPK CASCADE 2 26 0.0006016 0.004287
653 REGULATION OF CELL FATE COMMITMENT 2 26 0.0006016 0.004287
654 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 3 121 0.0006336 0.004508
655 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 2 27 0.0006492 0.004584
656 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 2 27 0.0006492 0.004584
657 INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 2 27 0.0006492 0.004584
658 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 2 27 0.0006492 0.004584
659 SUBSTRATE DEPENDENT CELL MIGRATION 2 27 0.0006492 0.004584
660 POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 2 28 0.0006985 0.004866
661 GASTRULATION WITH MOUTH FORMING SECOND 2 28 0.0006985 0.004866
662 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 2 28 0.0006985 0.004866
663 AUDITORY RECEPTOR CELL DIFFERENTIATION 2 28 0.0006985 0.004866
664 STEROID HORMONE MEDIATED SIGNALING PATHWAY 3 125 0.0006965 0.004866
665 MORPHOGENESIS OF A POLARIZED EPITHELIUM 2 28 0.0006985 0.004866
666 RESPONSE TO GONADOTROPIN 2 28 0.0006985 0.004866
667 MAMMARY GLAND DUCT MORPHOGENESIS 2 28 0.0006985 0.004866
668 METANEPHROS MORPHOGENESIS 2 28 0.0006985 0.004866
669 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 6 799 0.0007069 0.004917
670 REGULATION OF LIPID BIOSYNTHETIC PROCESS 3 128 0.0007462 0.005182
671 EMBRYONIC HINDLIMB MORPHOGENESIS 2 29 0.0007496 0.005183
672 REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 2 29 0.0007496 0.005183
673 NEUROBLAST PROLIFERATION 2 29 0.0007496 0.005183
674 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 3 129 0.0007632 0.005261
675 CELL JUNCTION ASSEMBLY 3 129 0.0007632 0.005261
676 PROTEIN LOCALIZATION TO CYTOSKELETON 2 30 0.0008025 0.005499
677 ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY 2 30 0.0008025 0.005499
678 RESPONSE TO EPIDERMAL GROWTH FACTOR 2 30 0.0008025 0.005499
679 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 2 30 0.0008025 0.005499
680 POSITIVE REGULATION OF CELL DIVISION 3 132 0.0008159 0.005583
681 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 3 133 0.0008339 0.005685
682 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 5 541 0.0008344 0.005685
683 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 5 541 0.0008344 0.005685
684 CARDIAC ATRIUM DEVELOPMENT 2 31 0.0008571 0.005825
685 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 6 829 0.0008575 0.005825
686 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 3 135 0.0008708 0.005898
687 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 3 135 0.0008708 0.005898
688 HINDBRAIN DEVELOPMENT 3 137 0.0009087 0.006107
689 POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION 2 32 0.0009134 0.006107
690 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 2 32 0.0009134 0.006107
691 REGULATION OF HEMOPOIESIS 4 314 0.0009063 0.006107
692 PATTERNING OF BLOOD VESSELS 2 32 0.0009134 0.006107
693 CELLULAR RESPONSE TO HORMONE STIMULUS 5 552 0.0009134 0.006107
694 POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 2 32 0.0009134 0.006107
695 BLOOD VESSEL REMODELING 2 32 0.0009134 0.006107
696 ACTIVATION OF MAPK ACTIVITY 3 137 0.0009087 0.006107
697 PEPTIDYL AMINO ACID MODIFICATION 6 841 0.0009242 0.00617
698 REGULATION OF CELL PROJECTION ORGANIZATION 5 558 0.0009587 0.006391
699 REGULATION OF MYELINATION 2 33 0.0009715 0.006458
700 POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 2 33 0.0009715 0.006458
701 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 3 141 0.0009875 0.006555
702 FOREBRAIN NEURON DEVELOPMENT 2 34 0.001031 0.0068
703 RESPONSE TO NITROGEN COMPOUND 6 859 0.001032 0.0068
704 LUNG EPITHELIUM DEVELOPMENT 2 34 0.001031 0.0068
705 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 2 34 0.001031 0.0068
706 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 3 143 0.001029 0.0068
707 CELLULAR RESPONSE TO STRESS 8 1565 0.001037 0.006827
708 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 3 145 0.001071 0.007036
709 NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 2 35 0.001093 0.007152
710 NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 2 35 0.001093 0.007152
711 REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES 2 35 0.001093 0.007152
712 PEPTIDYL SERINE MODIFICATION 3 148 0.001136 0.007422
713 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 2 36 0.001156 0.007535
714 POSITIVE CHEMOTAXIS 2 36 0.001156 0.007535
715 POSITIVE REGULATION OF CHROMOSOME ORGANIZATION 3 150 0.001181 0.007672
716 CHROMATIN REMODELING 3 150 0.001181 0.007672
717 SECRETION 5 588 0.001211 0.007849
718 RESPONSE TO BIOTIC STIMULUS 6 886 0.001211 0.007849
719 HINDLIMB MORPHOGENESIS 2 37 0.001221 0.00787
720 GLIAL CELL MIGRATION 2 37 0.001221 0.00787
721 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 2 37 0.001221 0.00787
722 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 2 37 0.001221 0.00787
723 REGULATION OF CHROMATIN ORGANIZATION 3 152 0.001226 0.007893
724 MULTI ORGANISM REPRODUCTIVE PROCESS 6 891 0.001247 0.008013
725 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 3 153 0.00125 0.008021
726 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 2 38 0.001288 0.008243
727 CYTOKINE SECRETION 2 38 0.001288 0.008243
728 BONE DEVELOPMENT 3 156 0.001322 0.008447
729 POSITIVE REGULATION OF VIRAL TRANSCRIPTION 2 39 0.001356 0.008599
730 NEGATIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 2 39 0.001356 0.008599
731 POSITIVE REGULATION OF HYDROLASE ACTIVITY 6 905 0.001351 0.008599
732 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 2 39 0.001356 0.008599
733 ASTROCYTE DIFFERENTIATION 2 39 0.001356 0.008599
734 COCHLEA DEVELOPMENT 2 39 0.001356 0.008599
735 HORMONE MEDIATED SIGNALING PATHWAY 3 158 0.001371 0.008678
736 CELLULAR RESPONSE TO CYTOKINE STIMULUS 5 606 0.001385 0.008754
737 MAMMARY GLAND MORPHOGENESIS 2 40 0.001427 0.00897
738 ENDOCRINE PANCREAS DEVELOPMENT 2 40 0.001427 0.00897
739 ENDODERMAL CELL DIFFERENTIATION 2 40 0.001427 0.00897
740 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 2 40 0.001427 0.00897
741 CELL CHEMOTAXIS 3 162 0.001473 0.009248
742 CELLULAR RESPONSE TO BIOTIC STIMULUS 3 163 0.001499 0.009374
743 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 2 41 0.001498 0.009374
744 LUNG ALVEOLUS DEVELOPMENT 2 41 0.001498 0.009374
745 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 4 360 0.001502 0.009381
746 REGULATION OF INTRACELLULAR TRANSPORT 5 621 0.001543 0.009623
747 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 3 166 0.001579 0.009838
748 POSITIVE REGULATION OF TRANSPORT 6 936 0.001606 0.009991
NumGOOverlapSizeP ValueAdj. P Value
1 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 13 1199 1.947e-09 9.045e-07
2 MACROMOLECULAR COMPLEX BINDING 14 1399 9.958e-10 9.045e-07
3 CHROMATIN BINDING 9 435 4.802e-09 1.487e-06
4 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 5 50 7.482e-09 1.738e-06
5 RECEPTOR BINDING 13 1476 2.395e-08 4.451e-06
6 SMAD BINDING 5 72 4.838e-08 7.491e-06
7 SEQUENCE SPECIFIC DNA BINDING 11 1037 6.566e-08 8.715e-06
8 REGULATORY REGION NUCLEIC ACID BINDING 10 818 8.324e-08 9.666e-06
9 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 5 90 1.494e-07 1.542e-05
10 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 7 328 2.636e-07 2.449e-05
11 TRANSCRIPTION FACTOR BINDING 8 524 4.122e-07 3.481e-05
12 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 8 629 1.63e-06 0.0001262
13 PROTEIN KINASE ACTIVITY 8 640 1.855e-06 0.0001326
14 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 6 315 4.094e-06 0.0002717
15 KINASE ACTIVITY 8 842 1.4e-05 0.0008136
16 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 5 226 1.401e-05 0.0008136
17 KINASE BINDING 7 606 1.54e-05 0.0008415
18 CYTOKINE RECEPTOR BINDING 5 271 3.352e-05 0.00173
19 PROTEIN HETERODIMERIZATION ACTIVITY 6 468 3.867e-05 0.001891
20 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 8 992 4.552e-05 0.002114
21 CORE PROMOTER BINDING 4 152 5.696e-05 0.00252
22 GROWTH FACTOR ACTIVITY 4 160 6.954e-05 0.002805
23 DOUBLE STRANDED DNA BINDING 7 764 6.771e-05 0.002805
24 ENZYME BINDING 10 1737 7.245e-05 0.002805
25 I SMAD BINDING 2 11 0.0001031 0.003833
26 PROTEIN DIMERIZATION ACTIVITY 8 1149 0.0001281 0.004577
27 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 6 588 0.0001365 0.004698
28 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 3 81 0.0001949 0.005524
29 C2H2 ZINC FINGER DOMAIN BINDING 2 14 0.0001702 0.005524
30 RECEPTOR SERINE THREONINE KINASE BINDING 2 15 0.0001962 0.005524
31 PROTEIN KINASE A CATALYTIC SUBUNIT BINDING 2 15 0.0001962 0.005524
32 OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR 2 15 0.0001962 0.005524
33 PROTEIN DOMAIN SPECIFIC BINDING 6 624 0.0001887 0.005524
34 BETA CATENIN BINDING 3 84 0.000217 0.00593
35 TRANSFORMING GROWTH FACTOR BETA BINDING 2 16 0.0002241 0.005948
36 PROTEIN COMPLEX BINDING 7 935 0.0002382 0.005981
37 CYTOKINE ACTIVITY 4 219 0.000233 0.005981
38 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 2 17 0.0002537 0.006203
39 CYTOKINE BINDING 3 92 0.0002839 0.006763
40 OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS 2 19 0.0003185 0.007397
41 PROTEIN SERINE THREONINE KINASE ACTIVITY 5 445 0.0003433 0.007779
42 DNA BINDING BENDING 2 20 0.0003536 0.00782
43 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 3 104 0.0004071 0.008795
44 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 3 105 0.0004187 0.00884
45 IONOTROPIC GLUTAMATE RECEPTOR BINDING 2 23 0.0004696 0.009483
46 FIBROBLAST GROWTH FACTOR BINDING 2 23 0.0004696 0.009483
NumGOOverlapSizeP ValueAdj. P Value
1 TRANSCRIPTION FACTOR COMPLEX 8 298 5.307e-09 3.099e-06
2 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 6 127 1.956e-08 5.711e-06
3 RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX 5 101 2.664e-07 5.185e-05
4 EXTRACELLULAR MATRIX 7 426 1.523e-06 0.0002223
5 EXTRACELLULAR SPACE 10 1376 9.586e-06 0.00112

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04390_Hippo_signaling_pathway 10 154 6.353e-15 1.144e-12
2 hsa04340_Hedgehog_signaling_pathway 5 56 1.341e-08 1.207e-06
3 hsa04520_Adherens_junction 5 73 5.189e-08 3.113e-06
4 hsa04350_TGF.beta_signaling_pathway 5 85 1.12e-07 5.041e-06
5 hsa04916_Melanogenesis 5 101 2.664e-07 9.589e-06
6 hsa04310_Wnt_signaling_pathway 5 151 1.961e-06 5.883e-05
7 hsa04330_Notch_signaling_pathway 2 47 0.001965 0.05053
8 hsa04510_Focal_adhesion 3 200 0.002684 0.05599
9 hsa04144_Endocytosis 3 203 0.002799 0.05599
10 hsa04010_MAPK_signaling_pathway 3 268 0.006085 0.1095
11 hsa04151_PI3K_AKT_signaling_pathway 3 351 0.01269 0.1908
12 hsa04110_Cell_cycle 2 128 0.01378 0.1908
13 hsa04380_Osteoclast_differentiation 2 128 0.01378 0.1908
14 hsa04014_Ras_signaling_pathway 2 236 0.04286 0.5143

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

LINC00968

 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-339-5p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-625-5p 14 TGFBR3 Sponge network -4.19 0 -3.002 0 0.578
2 FENDRR hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-3607-3p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-98-5p 12 TGFBR3 Sponge network -4.222 0 -3.002 0 0.57
3

LINC00702

 hsa-miR-130b-3p;hsa-miR-142-3p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200c-3p;hsa-miR-301a-3p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-96-5p 10 FOXF2 Sponge network -2.856 0 -1.7 0 0.554
4

RP11-389C8.2

 hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 11 TGFBR3 Sponge network -2.039 0 -3.002 0 0.55
5

AC109642.1

 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-424-5p;hsa-miR-590-3p 10 TGFBR3 Sponge network -2.791 0 -3.002 0 0.55
6

MAGI2-AS3

 hsa-miR-130b-3p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200c-3p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-9-5p 10 FOXF2 Sponge network -1.892 0 -1.7 0 0.539
7

TBX5-AS1

 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-450b-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 12 TGFBR3 Sponge network -2.108 0 -3.002 0 0.539
8

LINC00702

 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-34a-5p;hsa-miR-450b-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-625-5p;hsa-miR-7-1-3p 16 TGFBR3 Sponge network -2.856 0 -3.002 0 0.52
9

MAGI2-AS3

 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-7-1-3p 13 TGFBR3 Sponge network -1.892 0 -3.002 0 0.507
10

RP11-1024P17.1

 hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-424-5p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-625-5p 12 TGFBR3 Sponge network -2.062 0 -3.002 0 0.502
11 GAS6-AS2 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-590-5p;hsa-miR-7-1-3p 11 TGFBR3 Sponge network -1.761 0 -3.002 0 0.457
12

CTD-2013N24.2

 hsa-miR-15a-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-7-1-3p 11 TGFBR3 Sponge network -1.745 0 -3.002 0 0.448
13

RP11-456K23.1

 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-625-5p 13 TGFBR3 Sponge network -1.488 0 -3.002 0 0.43
14

LINC00702

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p 16 TGFB2 Sponge network -2.856 0 -1.547 1.0E-5 0.413
15

MIR497HG

 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-625-5p;hsa-miR-7-1-3p 11 TGFBR3 Sponge network -2.142 0 -3.002 0 0.404
16

WDFY3-AS2

 hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 10 TGFBR3 Sponge network -1.297 0 -3.002 0 0.403
17

CTD-2013N24.2

 hsa-miR-130b-3p;hsa-miR-142-3p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200c-3p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p 10 FOXF2 Sponge network -1.745 0 -1.7 0 0.388
18 AC079630.4 hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-3607-3p;hsa-miR-424-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-7-1-3p 10 TGFBR3 Sponge network -3.758 0 -3.002 0 0.377
19

RP11-1024P17.1

 hsa-miR-130b-3p;hsa-miR-142-3p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200c-3p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-9-5p 10 FOXF2 Sponge network -2.062 0 -1.7 0 0.358
20 RP11-354E11.2 hsa-miR-107;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-590-3p 10 TGFB2 Sponge network -2.138 0 -1.547 1.0E-5 0.356
21

RP11-1024P17.1

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-324-5p;hsa-miR-335-3p;hsa-miR-589-3p;hsa-miR-590-3p 13 TGFB2 Sponge network -2.062 0 -1.547 1.0E-5 0.354
22 LINC00261 hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 10 TGFBR3 Sponge network -2.566 0.00025 -3.002 0 0.346
23

AC109642.1

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-324-5p;hsa-miR-590-3p 11 TGFB2 Sponge network -2.791 0 -1.547 1.0E-5 0.343
24

MAGI2-AS3

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-193b-3p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-454-3p;hsa-miR-590-3p 14 TGFB2 Sponge network -1.892 0 -1.547 1.0E-5 0.342
25 NR2F1-AS1 hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-330-5p;hsa-miR-421;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p 11 WNT5A Sponge network -0.427 0.1559 -0.372 0.19306 0.336
26

CTD-2013N24.2

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-454-3p;hsa-miR-590-3p 13 TGFB2 Sponge network -1.745 0 -1.547 1.0E-5 0.334
27

TBX5-AS1

 hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-29a-5p;hsa-miR-421;hsa-miR-576-5p;hsa-miR-7-1-3p;hsa-miR-92a-3p 11 WNT5A Sponge network -2.108 0 -0.372 0.19306 0.323
28

MAGI2-AS3

 hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-29a-5p;hsa-miR-330-5p;hsa-miR-421;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p 11 WNT5A Sponge network -1.892 0 -0.372 0.19306 0.323
29

TBX5-AS1

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-324-5p;hsa-miR-335-3p;hsa-miR-590-5p 12 TGFB2 Sponge network -2.108 0 -1.547 1.0E-5 0.32
30

LINC00968

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-193b-3p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-590-3p;hsa-miR-590-5p 12 TGFB2 Sponge network -4.19 0 -1.547 1.0E-5 0.308
31

RP11-389C8.2

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-148b-3p;hsa-miR-186-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-589-3p;hsa-miR-590-3p 10 TGFB2 Sponge network -2.039 0 -1.547 1.0E-5 0.272

Quest ID: e0cebab3fd754f75293c6cf09ea5fdcf